Product

PhytoCyte

Technology Portfolio

PhytoCyte develops antimicrobial peptide technologies designed to support sustainable aquaculture, agriculture and future bio-integrated health applications through scalable recombinant production systems.

Product Platforms

Six recombinant AMP divisions built for global industries.

Each platform applies engineered antimicrobial peptide technology to replace antibiotics, toxic chemicals and conventional preservation systems across aquaculture, agriculture, livestock, sanitation, preservation and future human therapeutics.

aquai

Aquaculture & Aquafeed

Available now

Industry Focus

Marine agriculture and high-yield aquaculture operations.

Core Application

Mass-producing recombinant AMPs to replace traditional antibiotics in fish and shrimp feed, improving stock survivability, feed conversion rates and natural immune response against aquatic pathogens.

Differentiator

Designed for feed-integrated protection in aquaculture systems where antibiotic residues can create export restrictions and long-term supply chain risk.

Key Applications

Parasite control

Peptides targeting Ichthyophthirius multifiliis, one of the major threats in fish production.

Vibrio control

Fish-derived Hepcidins and Piscidins designed to target Vibrio pathogens.

Streptococcus pressure

AMP-based support against Streptococcus infections affecting aquatic stock health.

Development Status100%

Commercially Available

agrai

Agricultural & Plant Sciences

2027

Industry Focus

Crop protection and agricultural yield enhancement.

Core Application

Developing target-specific biopesticides and bio-stimulants. These protein-based solutions selectively neutralise agricultural threats and degrade safely, leaving zero toxic chemical residues on crops or in soil.

Differentiator

A biodegradable alternative to chemical pesticides for growers facing residue limits, soil contamination and increasing regulatory pressure.

Key Applications

Fungal defence

Targets azole-resistant Aspergillus and Candida strains.

Low concentration efficacy

PepBiotics show efficacy at below 1uM concentrations without host toxicity.

Parasitic defence

Targets Leishmania, Eimeria causing coccidiosis, and Histomonas.

Internal organelle targeting

Unlike bacterial attacks, these peptides can target internal organelles in parasites.

Banana fungal protection

A product development opportunity focused on fungal protection in banana production.

Development Status65%

Development Phase

vetai

Veterinary & Livestock Health

2027

Industry Focus

Terrestrial livestock and veterinary medicine.

Core Application

Creating specialised enzymes, vaccines and targeted immune-boosting supplements to protect livestock from bacterial infections and improve herd health without relying on broad-spectrum antibiotics.

Differentiator

Built for species-specific interventions across swine, cattle and poultry production systems where antibiotic dependency remains high.

Key Applications

Swine production

Combats post-weaning diarrhoea and supports digestion after weaning.

Mastitis control

Thanatin peptide targets S. aureus and remains stable at body temperature.

Respiratory health

BMAP-28 effectively targets Mannheimia haemolytica in cattle respiratory disease.

Climate impact

Bacteriocins such as Bovicin HC5 may reduce methane production in the rumen.

Poultry protection

Addresses Necrotic Enteritis caused by Clostridium perfringens and Salmonella-related production losses.

Early chick survival

ABD1 peptide in-ovo administration reduced early chick mortality in E. coli infections.

Gut health bonus

Sublancin improves villus height and reduces pro-inflammatory cytokines, supporting feed efficiency.

Development Status60%

Pre-Commercial Validation

presai

Advanced Bio-Preservatives

Concept phase

Industry Focus

Food, beverage, cosmetic and material safety.

Core Application

Utilising AMPs as clean-label biological preservatives to extend shelf life by targeting spoilage-causing bacteria, moulds and fungi.

Differentiator

A future-facing preservation platform for brands seeking to remove controversial preservatives such as parabens and benzoates from their supply chains.

Key Applications

Food preservation

Targets spoilage bacteria, moulds and fungi to extend product shelf life.

Cosmetic preservation

Potential application for cleaner preservation systems in cosmetic formulations.

Clean-label positioning

Supports brands moving away from synthetic or controversial preservatives.

Material safety

Potential use in protecting materials vulnerable to microbial spoilage.

Development Status30%

Concept Evaluation

disai

Disinfectants & Industrial Sterilisation

2027

Industry Focus

Industrial cleaning, facility sterilisation and surface sanitation.

Core Application

Formulating advanced protein-based enzymatic cleaners capable of actively breaking down stubborn bacterial biofilms on industrial processing equipment and high-risk facility surfaces.

Differentiator

Designed to replace harsh chemical cleaning systems with targeted biological activity against persistent microbial contamination.

Key Applications

Biofilm disruption

Breaks down stubborn bacterial biofilms that conventional cleaning systems may leave behind.

Processing equipment

Supports sanitation of industrial processing lines and high-contact surfaces.

Facility sterilisation

Designed for high-risk environments where microbial control is critical.

Development Status55%

Product Development

humai

Human Therapeutics & Health

In development

Industry Focus

Clinical, pharmaceutical and dermatological applications.

Core Application

Combatting antimicrobial resistance through next-generation antibiotics, advanced wound care gels for chronic infections and microbiome-safe therapies.

Differentiator

A long-term therapeutic platform designed to physically dismantle bacterial cell walls without harming healthy human tissue.

Key Applications

AMR therapeutics

Future applications for infections where traditional antibiotics are losing effectiveness.

Wound care

Advanced gels for chronic wounds and difficult-to-treat infections.

Microbiome-safe therapies

Targeted antimicrobial action designed to reduce collateral damage to beneficial microbiota.

Development Status10%

Research & Discovery

The Crisis

The antibiotic era is reaching a breaking point.

Antimicrobial resistance is no longer a distant scientific warning. It is a global systems failure spreading across human health, animal production, agriculture and industrial supply chains.

The overuse of antibiotics in the food chain accelerates the evolution of resistant pathogens before they ever reach hospitals, while toxic chemicals continue to leave residues in soil, crops, water systems and consumer products.

PhytoCyte was built to confront this crisis with AI-supported antimicrobial peptide technology: precise, biodegradable biological systems designed to replace antibiotics and harsh chemical interventions.

10M

Potential annual deaths linked to antimicrobial resistance by 2050 if effective alternatives are not deployed at scale.

70%

Of global antibiotic use occurs in animals rather than humans, creating evolutionary pressure across the food chain.

Where PhytoCyte intervenes

aquai

Aquaculture

Antibiotic use in fish and shrimp farming creates residue risks, export restrictions and fragile stock survival. AQUAI targets aquatic pathogens such as Ichthyophthirius multifiliis, Vibrio and Streptococcus through recombinant AMP systems designed for feed-integrated protection.

vetai

Livestock Health

Broad-spectrum antibiotics remain deeply embedded in livestock production. VETAI addresses post-weaning diarrhoea in swine, mastitis and respiratory infections in cattle, poultry gut disease, Salmonella pressure and early chick mortality linked to E. coli.

agrai

Agriculture

Chemical pesticides leave residues on crops and in soil. AGRAI introduces biodegradable AMP-based biopesticides and bio-stimulants targeting fungal and parasitic threats including azole-resistant Aspergillus, Candida, Eimeria and Histomonas.

disai

Industrial Sterilisation

Biofilms survive where conventional cleaning fails. DISAI develops protein-based enzymatic cleaners capable of breaking down persistent bacterial biofilms on processing equipment and high-risk facility surfaces.

presai

Bio-Preservation

Food, beverage and cosmetic brands are under pressure to move beyond controversial preservatives. PRESAI explores clean-label biological preservation systems targeting spoilage bacteria, moulds and fungi without parabens or benzoates.

humai

Human Therapeutics

The long-term ambition is clinical. HUMAI focuses on future AMP-based therapies for antimicrobial resistance, chronic wound infections and cases where traditional antibiotics are no longer enough.

PhytoCyte is not treating symptoms. It is replacing the system that created them.

By engineering antimicrobial peptides for aquaculture, livestock, agriculture, industrial sanitation, preservation and future human therapeutics, PhytoCyte offers a natural, biodegradable and scalable alternative to the antibiotic and chemical dependency that defines today’s production systems.